position: EnglishChannel > Visual Stories > Article

Beijing positively reacts to the new epidemic situation

Source: Science and Technology Daily| 2020-06-19 17:31:48| Author: Science and Technology Daily

Since June 11, when the new confirmed domestically transmitted COVID-19 cases in Beijing were continually reported, Beijing has gradually expanded its nucleic acid detection for the novel coronavirus. 

In recent days, based on the principle of “those who should be tested will be tested, and those who wish to be tested will be tested”, Beijing has started novel coronavirus nucleic acid test for its citizens. According to reports, 193 sampling sites have been set up in Beijing. 

  

The staff in protection clothing offer help to people who came to take the nucleic acid test (NAT) in the test center at Guang'an Stadium in Xicheng District, Beijing, June 16,2020. (Photo/Zhou Weihai)

Residents undergo the nucleic acid test at Guang'an stadium in Beijing's Xicheng district,June 16,2020. (Photo/Zhou Weihai) 

An epidemic prevention team conducts disinfection at the Beijing Railway Station, June 18,2020 (Photo/Zhou Weihai)

Epidemic prevention workers disinfect every seats carefully in the Beijing Railway Station, June 18,2020 (Photo/Zhou Weihai)

  

People buy fruits normally in the market after new Covid-19 cases reported in Beijing,June 18,2020 (Photo/Zhou Weihai)

  

Editor:余昊原

Top News

  • At 6:57 a.m. on September 3, Air China CA746 carrying passengers from Phnom Penh, Cambodia, landed at Beijing Capital International Airport. It was the first international flight to Beijing Capital International Airport since the Civil Aviation Administration of China announced the gradual resumption of direct international flights to Beijing without passing through one of the designated first points of entry into China.

Haploid induction greatly speeds up maize breeding process

The new haploid breeding technology has significantly sped up the process of maize breeding in China, said Dai Jingrui, an academician of the Chinese Academy of Engineering (CAE) and a professor at China Agricultural University (CAU).

A Future to Expect: International S&T Community Expresses High Hope in Cooperation with Peers in China

According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) of China, making them the first batch in this category. The two vaccines were developed respectively by Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.

Copyright © Science and Technology Daily, All Rights Reserved

mailto: yuhy@weboomania.com